Pavot V - Search Results

1

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.

Asthagiri Arunkumar G, McMahon M, Pavot V, Aramouni M, Ioannou A, Lambe T, Gilbert S, Krammer F. Asthagiri Arunkumar G, et al. Among authors: pavot v. Vaccine. 2019 Sep 3;37(37):5567-5577. doi: 10.1016/j.vaccine.2019.07.095. Epub 2019 Aug 6. Vaccine. 2019. PMID: 31399277 Free PMC article.

2

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.

McMahon M, Asthagiri Arunkumar G, Liu WC, Stadlbauer D, Albrecht RA, Pavot V, Aramouni M, Lambe T, Gilbert SC, Krammer F. McMahon M, et al. Among authors: pavot v. Front Immunol. 2019 Aug 21;10:2005. doi: 10.3389/fimmu.2019.02005. eCollection 2019. Front Immunol. 2019. PMID: 31497029 Free PMC article.

3

Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.

Pavot V, Sebastian S, Turner AV, Matthews J, Gilbert SC. Pavot V, et al. Methods Mol Biol. 2017;1581:97-119. doi: 10.1007/978-1-4939-6869-5_6. Methods Mol Biol. 2017. PMID: 28374245

4

Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs.

Everett HE, van Diemen PM, Aramouni M, Ramsay A, Coward VJ, Pavot V, Canini L, Holzer B, Morgan S; Dynamics sLoLa Consortium; Woolhouse MEJ, Tchilian E, Brookes SM, Brown IH, Charleston B, Gilbert S. Everett HE, et al. Among authors: pavot v. J Virol. 2021 Jan 28;95(4):e01787-20. doi: 10.1128/JVI.01787-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33268518 Free PMC article.

5

Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.

Pavot V, Berthet M, Rességuier J, Legaz S, Handké N, Gilbert SC, Paul S, Verrier B. Pavot V, et al. Nanomedicine (Lond). 2014 Dec;9(17):2703-18. doi: 10.2217/nnm.14.156. Nanomedicine (Lond). 2014. PMID: 25529572

6

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

Climent N, Munier S, Piqué N, García F, Pavot V, Primard C, Casanova V, Gatell JM, Verrier B, Gallart T. Climent N, et al. Among authors: pavot v. Vaccine. 2014 Oct 29;32(47):6266-76. doi: 10.1016/j.vaccine.2014.09.010. Epub 2014 Sep 19. Vaccine. 2014. PMID: 25240755

7

Ebola virus vaccines: Where do we stand?

Pavot V. Pavot V. Clin Immunol. 2016 Dec;173:44-49. doi: 10.1016/j.clim.2016.10.016. Epub 2016 Oct 28. Clin Immunol. 2016. PMID: 27910805 Review.

8

New insights in mucosal vaccine development.

Pavot V, Rochereau N, Genin C, Verrier B, Paul S. Pavot V, et al. Vaccine. 2012 Jan 5;30(2):142-54. doi: 10.1016/j.vaccine.2011.11.003. Epub 2011 Nov 12. Vaccine. 2012. PMID: 22085556 Review.

9

Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.

Pavot V, Rochereau N, Primard C, Genin C, Perouzel E, Lioux T, Paul S, Verrier B. Pavot V, et al. J Control Release. 2013 Apr 10;167(1):60-7. doi: 10.1016/j.jconrel.2013.01.015. Epub 2013 Jan 23. J Control Release. 2013. PMID: 23352911

10

Recent progress in HIV vaccines inducing mucosal immune responses.

Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S. Pavot V, et al. AIDS. 2014 Jul 31;28(12):1701-18. doi: 10.1097/QAD.0000000000000308. AIDS. 2014. PMID: 25009956 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page